1 |
B. Siekmann and K. Westesen, Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1, 123-126 (1992).
|
2 |
M.D. Josh and R.H. Muller, Lipid nanoparticles for parenteral delivery of actives, Eur. J. Pharm. 71, 161-72 (2008).
DOI
|
3 |
C. Schwartz and W. Mehnert, Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN), Int. J. Pharm, 157, 171-179 (1997).
DOI
|
4 |
A. Misra, K. Jinturkar, D. Patel, J. Lalani and M. Chougule, recent advances in liposomal dry powder formulations: preparation and evaluation, Expert Opin. Drug Deliv. 6, 71-89 (2009).
DOI
|
5 |
A.C.Bach, J. Ferezou, and A. Frey, Phospholipid-rich particles in commercial parenteral fat emulsions. An overview, Prog. Lipid Res. 35, 133-53 (1996)
DOI
|
6 |
C. Schwartz, J.S. Mehnert, J.S. Lucks, R.H. Muller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization, J. Control. Rel. 30, 83-96. (1994).
DOI
|
7 |
M. Grit and D.J.A. Crommelin, The effect of aging on the physical stability of liposome dispersions, Chem. Phys. Lipids. 62, 113-122. (1992).
DOI
|
8 |
M.F. Powell, T. Nguyen and L. Baloian, Compendium of excipients for parenteral formulations, PDA J. Pharm. Sci. Tech. 52, 238-311 (1998).
|
9 |
Y.N.Konan, R. Gurny, and E. Allermann, Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles, Int. J. Pharm. 354, 242-247 (2002)
DOI
|
10 |
S. Kamiya, T. Kurita, A. Miyagishima and M. Arakawa, Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols, Drug Dev. Ind. Pharm. 38, 1022-8 (2009).
DOI
|
11 |
M. Ausborn, P. Nuhn, P. and H. Schreier, Stabilization of liposomes by freeze-thaw and lyophilization techniques: problems and opportunities, Eur. J. Pharm. Biopharm. 38, 133-139 (1992).
|
12 |
G. Strauss, P. Schurtenberger, P. and H. Hauser, The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying, Biochim. Biophys. Acta. 858, 169-180 (1986).
DOI
ScienceOn
|
13 |
C. Freitas and R.H. Muller, Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles ( ) dispersion, Int. J. Pharm. 168, 221-229 (1998).
DOI
|
14 |
L. Zhang, L. liu, Y. Qian, and Y. Chen, The effect of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM), Eur. J. Pharm. Biopharm. 69, 750-759 (2008).
DOI
|
15 |
H. Ohshima, A. Migagishima, T. Kurita, Y. Makino, Y. Iwao, T. Sonobe and S. Itai, Freeze-dried nifedifine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution, Int. J. Pharm. 377, 180-184 (2008).
DOI
|
16 |
D. Law, W. Wang, E.A. Schmitt, Y. Qiu, S.L. Krill, and J.J.Fort, Properties of rapidly dissolving eutectic mixtures of poly (ethylene glycol) and fenofibrate: the eutectic microstructure, J. Pharm. Sci. 92, 505-515 (2003).
DOI
|
17 |
M.G. Anhorn, H.C. Mahler, K. Langer, Freeze-drying of human serum albumin (HSA) nanoparticles with different excipients, Int. J. Pharm. 363, 162-169 (2008).
DOI
|
18 |
P.D.Marcato and N. Duran, New aspects of nanopharmaceutical delivery systems, J. Nanosci. Nanotechnol., 8, 2216-29 (2008).
DOI
|